Exploring the intricacies of antimicrobial resistance: Understanding mechanisms, overcoming challenges, and pioneering innovative solutions

IF 4.7 3区 医学 Q1 PHARMACOLOGY & PHARMACY European journal of pharmacology Pub Date : 2025-07-05 Epub Date: 2025-03-14 DOI:10.1016/j.ejphar.2025.177511
Shahbaz Ul Haq , Wang Ling , Amjad Islam Aqib , Huang Danmei , Muhammad Tahir Aleem , Mahreen Fatima , Saad Ahmad , Fenfei Gao
{"title":"Exploring the intricacies of antimicrobial resistance: Understanding mechanisms, overcoming challenges, and pioneering innovative solutions","authors":"Shahbaz Ul Haq ,&nbsp;Wang Ling ,&nbsp;Amjad Islam Aqib ,&nbsp;Huang Danmei ,&nbsp;Muhammad Tahir Aleem ,&nbsp;Mahreen Fatima ,&nbsp;Saad Ahmad ,&nbsp;Fenfei Gao","doi":"10.1016/j.ejphar.2025.177511","DOIUrl":null,"url":null,"abstract":"<div><div>Antimicrobial resistance (AMR) poses a growing global threat. This review examines AMR from diverse angles, tracing the story of antibiotic resistance from its origins to today's crisis. It explores the rise of AMR, from its historical roots to the urgent need to counter this escalating menace. The review explores antibiotic classes, mechanisms, resistance profiles, and genetics. It details bacterial resistance mechanisms with illustrative examples. Multidrug-resistant bacteria spotlight AMR's resilience. Modern AMR control offers hope through precision medicine, stewardship, combination therapy, surveillance, and international cooperation. Converging traditional and innovative treatments presents an exciting frontier as novel compounds seek to enhance antibiotic efficacy. This review calls for global unity and proactive engagement to address AMR collectively, emphasizing the quest for innovative solutions and responsible antibiotic use. It underscores the interconnectedness of science, responsibility, and action in combatting AMR. Humanity faces a choice between antibiotic efficacy and obsolescence. The call is clear: unite, innovate, and prevail against AMR.</div></div>","PeriodicalId":12004,"journal":{"name":"European journal of pharmacology","volume":"998 ","pages":"Article 177511"},"PeriodicalIF":4.7000,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014299925002651","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/14 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Antimicrobial resistance (AMR) poses a growing global threat. This review examines AMR from diverse angles, tracing the story of antibiotic resistance from its origins to today's crisis. It explores the rise of AMR, from its historical roots to the urgent need to counter this escalating menace. The review explores antibiotic classes, mechanisms, resistance profiles, and genetics. It details bacterial resistance mechanisms with illustrative examples. Multidrug-resistant bacteria spotlight AMR's resilience. Modern AMR control offers hope through precision medicine, stewardship, combination therapy, surveillance, and international cooperation. Converging traditional and innovative treatments presents an exciting frontier as novel compounds seek to enhance antibiotic efficacy. This review calls for global unity and proactive engagement to address AMR collectively, emphasizing the quest for innovative solutions and responsible antibiotic use. It underscores the interconnectedness of science, responsibility, and action in combatting AMR. Humanity faces a choice between antibiotic efficacy and obsolescence. The call is clear: unite, innovate, and prevail against AMR.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
探索抗菌素耐药性的复杂性:理解机制,克服挑战,开拓创新解决方案。
抗菌素耐药性(AMR)构成日益严重的全球威胁。本综述从多个角度考察了抗生素耐药性,追溯了抗生素耐药性从起源到今天的危机的故事。它探讨了抗生素耐药性的兴起,从其历史根源到应对这一不断升级的威胁的迫切需要。这篇综述探讨了抗生素的种类、机制、耐药概况和遗传学。它用说明性的例子详细说明了细菌的耐药机制。耐多药细菌凸显了抗菌素耐药性的韧性。现代抗微生物药物耐药性控制通过精准医疗、管理、联合治疗、监测和国际合作带来了希望。融合传统和创新的治疗提出了一个令人兴奋的前沿新化合物寻求提高抗生素的功效。本综述呼吁全球团结和积极参与,共同应对抗生素耐药性,强调寻求创新解决方案和负责任的抗生素使用。它强调了科学、责任和行动在抗击抗生素耐药性方面的相互联系。人类面临着抗生素有效性和过时之间的选择。呼吁是明确的:团结、创新,战胜抗生素耐药性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.00
自引率
0.00%
发文量
572
审稿时长
34 days
期刊介绍: The European Journal of Pharmacology publishes research papers covering all aspects of experimental pharmacology with focus on the mechanism of action of structurally identified compounds affecting biological systems. The scope includes: Behavioural pharmacology Neuropharmacology and analgesia Cardiovascular pharmacology Pulmonary, gastrointestinal and urogenital pharmacology Endocrine pharmacology Immunopharmacology and inflammation Molecular and cellular pharmacology Regenerative pharmacology Biologicals and biotherapeutics Translational pharmacology Nutriceutical pharmacology.
期刊最新文献
Nitrate treatment decreases circulating matrix metalloproteinases concentrations in overweight women Multi-omics reveals rutin directly targets RUNX1 to disrupt the RUNX1/TET2 complex and alleviate NAFLD via TLR4/NF-κB inhibition Involvement of the cannabinoid system in stress-induced reinstatement to opioid use: a study in CB1 knockout mice of both sexes Genetic variations in GLP-1R: Impact on diabetes and obesity therapeutics Dopamine-induced vasoconstriction is attenuated by endothelial nitric oxide in isolated rat aorta
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1